iSpecimen Inc.
ISPCNASDAQHealthcareDiagnostics & Research

About iSpecimen

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecimens, including Biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; Solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and Hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. The company serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.

Company Information

CEOKatharyn Field
Founded2009
IPO DateJune 17, 2021
Employees24
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone781 301 6700
Address
8 Cabot Road Woburn, Massachusetts 02420 United States

Corporate Identifiers

CIK0001558569
CUSIP45032V108
ISINUS45032V2079
EIN27-0480143
SIC8731

Leadership Team & Key Executives

Katharyn Field
Chief Executive Officer, President, Secretary and Treasurer
Yuying Liang
Chief Financial Officer